期刊文献+

结直肠癌中Runx3和C-myc基因的表达 被引量:5

Expression of Runx3 and C-myc in human colorectal cancer
下载PDF
导出
摘要 目的探讨Runx3和C-myc基因在结直肠癌组织中的表达及其与临床病理参数的关系。方法采用实时荧光定量PCR技术检测38例结直肠癌病人的癌组织及相应癌旁正常组织(距癌缘>5 cm)中Runx3 mRNA和C-myc mRNA的表达水平;Western-blot免疫印迹法检测63例结直肠癌病人的癌组织及相应癌旁正常组织中Runx3蛋白和C-myc蛋白的表达水平。将实验数据按照临床病理特点进行分层分析,采用统计软件SPSS 13.0进行统计,了解Runx3、C-myc的表达与结直肠癌患者主要临床病理参数之间的关联性。结果 mRNA水平与蛋白水平提示:Runx3在结直肠癌组织中的表达下调,C-myc在结直肠癌组织中的表达上调,二者的蛋白表达呈负相关(Protein levels,r=-0.398,P=0.001)。且其各自的表达在不同Dukes分期、肿瘤浸润深度、淋巴结转移状态及病理分化类型差异均具有统计学意义(P<0.05),临床分期越晚、病理分化越低,Runx3表达下调、C-myc表达上调越明显。结论 Runx3和C-myc基因表达异常,参与了结直肠癌的发生、发展,并与病员临床病理参数密切相关。 Objective To investigate Runx3 and C-myc expressions in colorectal cancer and their relationship with the clinicopathological parameters. Methods Real-time quantitative PCR was used to detect Runx3 and C-myc mRNA expressions in 38 colorectal cancer tissues and matched adjacent tissues, and Runx3 and C-myc expressions was detected by Western blotting in 63 pairs of colorectal cancer and adjacent tissues. The results were stratified according to the clinicopathological characteristics to examine the relationship of Runx3 and C-myc expressions with the clinicopathological factors in the patients. Results Runx3 expression was down-regulated and C-myc expression up-regulated at both mRNA and protein levels in colorectal cancer tissues compared with the normal tissues, and their protein expressions exhibited an inverse correlation (r=-0.398, P=0.001). Runx3 and C-myc expressions differed significantly between tumors with different Dukes stages, depths of tumor invasion, lymph node statuses, or histological differentiation (P〈0.05);Runx3 down-regulation and C-myc up-regulation were more obvious in tumors in advanced Dukes stage and in poorly differentiated tumors. Conclusion Abnormal expressions in Runx3 and C-myc may contribute to the occurrence and development of colorectal cancer and are closed correlated with the patient's clinicopathological parameters.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2014年第7期1042-1047,共6页 Journal of Southern Medical University
基金 广州市海珠区科技计划项目(2010-C-17)
关键词 结直肠癌 RUNX3 C-MYC 基因表达 colorectal cancer Runx3 C-myc gene expression
  • 相关文献

参考文献16

  • 1Parsons DW,Wang TL,Samuels Y. Colorectal cancer:muta-tions in a signalling pathway[J].NATURE,2005,(7052):792.
  • 2Migheli F,Migliore L. Epigenetics of colorectal cancer[J].CLINICAL GENETICS,2012,(04):312-318.
  • 3He C,Hu H,Braren R. C-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo[J].DEVELOPMENT,2008,(14):2467-2477.
  • 4Wolffe AP,Matzke MA. Epigeneties:regulation through repression[J].SCIENCE,1999,(5439):481-486.
  • 5Cho KR,Vogelstein B. Genetic alterations in the adenoma-carcinoma sequence[J].CANCER,1992,(6 Suppl):1727-1731.
  • 6Jones PA,Laird PW. Cancer epigenetics comes of age[J].Nature genetics,1999,(02):163-167.
  • 7Tan SH,Ida H,Lau QC. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3[J].Oncology Reports,2007,(05):1225-1230.
  • 8Smith E,De Young NJ,Pavey SJ. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma[J].Molecular Cancer Therapautics,2008.75.
  • 9Kato N,Tamura G,Fukase M. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants[J].AMERICAN JOURNAL OF PATHOLOGY,2003,(02):387-391.
  • 10张海元,刘娟.结直肠癌细胞系中Runx3及Runx2基因表达分析[J].长江大学学报(自科版)(下旬),2008,5(2):1-3. 被引量:6

二级参考文献4

共引文献8

同被引文献87

  • 1Yoshimitsu Akiyama.Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas[J].World Journal of Gastroenterology,2010,16(10):1201-1208. 被引量:9
  • 2郑玮,邹兆伟,钟林,黄宗海.Runx3和C-myc基因在结直肠癌组织中的表达及临床意义[J].中国老年学杂志,2014,34(9):2422-2424. 被引量:2
  • 3Wang B, Liu SZ, Zheng RS, et al. Time trends of ovarian cancer incidence in China[J]. Asian Pac J Cancer Prev, 2014, 15(1): 191-3.
  • 4Vergote I. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer[J]. N Engl J Med, 2010, 363(10): 943-53.
  • 5Mazda M, Nishi K, Naito Y, et al. E-cadherin is transcriptionally activated via suppression of ZEB1 transcriptional repressor by small RNA-mediated gene silencing [J]. PLoS One, 2011, 6(12): e28688.
  • 6Vandewalle CV, Berx G. The role of the ZEB family of transcription factors in development and disease[J]. Cell Mol Life Sci, 2009, 66 (5): 773-87.
  • 7Kahlert C, Lahes S, Radhakrishnan P, et al. Overexpression of ZEB2 at the invasion front of eolorectal cancer is an Independent prognostic marker and regulates tumor invasion in vitro [J]. Clin Cancer Res, 2011, 17(24): 7654-63.
  • 8Okugawa Y, Inoue Y, Tanaka K, et al. Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer[J]. Clin Exp Metastasis, 2013, 30(4): 417-29.
  • 9Karihtala P, Auvinen P, Kauppila S, et al. Vimentin, zebl and sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype[J]. Breast Cancer Res Treat, 2013, 138(1): 81-90.
  • 10Cole MD, Mcmahon SB. The Myc oncoprotein: a critical evaluation oftransactivation and target gent regulation[J]. Oncogene, 1999, 18 (19): 2916-24.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部